上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02607 上海医药

交易中 06-03 15:38:05

11.580

-0.100

-0.86%

最高11.680	最低11.520	成交量218.10万
今开11.670	昨收11.680	日振幅1.37%
总市值429.39亿	流通市值106.43亿	总股本37.08亿
成交额2,522万	换手率0.24%	流通股本9.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02607","market":"HK","secType":"STK","nameCN":"上海医药","latestPrice":11.58,"timestamp":1780472279491,"preClose":11.68,"halted":0,"volume":2181022,"delay":0,"changeRate":-0.008561643835616408,"floatShares":919072704,"shares":3708000000,"eps":1.781231722214386,"marketStatus":"交易中","change":-0.1,"latestTime":"06-03 15:38:05","open":11.67,"high":11.68,"low":11.52,"amount":25217555,"amplitude":0.013699,"askPrice":11.58,"askSize":25900,"bidPrice":11.57,"bidSize":10300,"shortable":3,"etf":0,"ttmEps":1.8076020653345866,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1780474200000},"marketStatusCode":2,"adr":0,"listingDate":1305820800000,"exchange":"SEHK","adjPreClose":11.68,"dividendRate":0.038731,"openAndCloseTimeList":[[1780450200000,1780459200000],[1780462800000,1780473600000]],"volumeRatio":0.725558,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"601607","market":"SH","secType":"STK","nameCN":"上海医药","latestPrice":16.3,"timestamp":1780470000000,"preClose":16.5,"halted":0,"volume":9068000,"delay":0,"premium":"-38.58"}},"requestUrl":"/m/hq/s/02607","defaultTab":"news","newsList":[{"id":"1139288356","title":"上海医药5月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1139288356","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1139288356?lang=zh_cn&edition=full","pubTime":"2026-06-01 17:45","pubTimestamp":1780307143,"startTime":"0","endTime":"0","summary":"上海医药于2026年6月1日披露截至2026年5月31日的股份变动月报表。公告显示，公司在报告期内的法定注册股本维持人民币3,708,361,809元不变，包含H股普通股919,072,704股和未在香港联交所上市的A股普通股2,789,289,105股，各类股份数量与上月保持一致。按照上述报告，上海医药的已发行股份总数未发生变化，公司确认遵守香港联交所《上市规则》及相关法律规定，月报由联席公司秘书钟涛提交。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638638206","title":"上海医药(601607.SH)子公司山东信谊成为盐酸曲唑酮片上市许可持有人","url":"https://stock-news.laohu8.com/highlight/detail?id=2638638206","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638638206?lang=zh_cn&edition=full","pubTime":"2026-05-28 15:37","pubTimestamp":1779953868,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药(601607.SH)发布公告，近日，公司下属山东信谊制药有限公司(简称“山东信谊”)收到国家药品监督管理局颁发的《药品补充申请批准通知书》(通知书编号：2026B02904)，其同意将盐酸曲唑酮片上市许可持有人变更为山东信谊制药有限公司。盐酸曲唑酮片是河北龙海药业股份有限公司于2025年在中国批准上市的产品，适用于抑郁症的治疗，对伴有或不伴有焦虑的患者均有效。2026年5月，山东信谊就该药品上市许可持有人变更向国家药监局提出注册上市申请并获批准。截至公告日，公司针对该药品已投入约人民币520万元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1447087.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0099","BK0012","BK0209","601607","BK0028","BK0184","BK1197","BK0097","BK0187","BK0020","BK0188","02607","BK0196","IPOS","BK0175","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638689943","title":"上海医药（601607）披露2026年中期分红安排公告，5月27日股价上涨0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638689943","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638689943?lang=zh_cn&edition=full","pubTime":"2026-05-27 22:37","pubTimestamp":1779892632,"startTime":"0","endTime":"0","summary":"截至2026年5月27日收盘，上海医药报收于16.39元，较前一交易日上涨0.31%，最新总市值为607.8亿元。该股当日开盘16.35元，最高16.42元，最低16.09元，成交额达1.84亿元，换手率为0.41%。近日，上海医药集团股份有限公司发布《关于2026年中期分红安排的公告》。该议案尚需提交公司2025年年度股东会审议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052700046303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0196","BK1197","BK0209","601607","BK0175","BK0183","BK0097","BK0012","BK0184","BK0187","BK0099","BK0020","BK0188","BK0028","02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638683269","title":"上海医药：公司工业板块覆盖化学和生物药品、现代中药和保健品、医疗器械等范围","url":"https://stock-news.laohu8.com/highlight/detail?id=2638683269","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638683269?lang=zh_cn&edition=full","pubTime":"2026-05-27 20:33","pubTimestamp":1779885180,"startTime":"0","endTime":"0","summary":"证券日报网5月27日讯 ，上海医药在接受调研者提问时表示，公司工业板块覆盖化学和生物药品、现代中药和保健品、医疗器械等范围，聚焦免疫、精神神经、肿瘤、心血管、消化代谢及抗感染等疾病领域。公司在国内12个省市以及海外建有药品生产基地，常年生产约800个药品品规，30多种剂型。2025年公司实现工业销售过亿产品数量40个，其中过10亿产品数量4个。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-05-27/doc-inhzizpk0677953.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-05-27/doc-inhzizpk0677953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0175","BK0209","BK0099","BK0184","BK1197","BK0187","BK0028","09996","BK0183","BK0097","601607","BK0188","BK1574","BK0012","BK1100","BK0196","BK1583","02607","159883","BK0020"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638832606","title":"上海医药：截至2026年第一季度B001项目用于治疗视神经脊髓炎（NMOSD）的III期临床试验主研究（RCP）已完成揭盲","url":"https://stock-news.laohu8.com/highlight/detail?id=2638832606","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638832606?lang=zh_cn&edition=full","pubTime":"2026-05-27 20:32","pubTimestamp":1779885120,"startTime":"0","endTime":"0","summary":"证券日报网5月27日讯，上海医药在接受调研者提问时表示，截至2026年第一季度，B001项目用于治疗视神经脊髓炎(NMOSD)的III期临床试验主研究(RCP)已完成揭盲。研究结果显示，B001较安慰剂可显著降低AQP4-IGG阳性NMOSD的复发风险；并且B001较已获批同类药物具备更好的安全性，输液相关不良反应、感染相关不良反应、免疫球蛋白降低和血液学相关不良反应的发生率均更低。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-05-27/doc-inhzizpk0677917.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-05-27/doc-inhzizpk0677917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0187","BK0097","BK0209","BK1197","BK0028","BK0196","BK0184","BK0012","BK0183","BK0188","BK0020","BK0099","BK4134","III","BK0175","601607","02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638268325","title":"上海医药：公司始终致力于优化业务结构，提升盈利水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2638268325","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638268325?lang=zh_cn&edition=full","pubTime":"2026-05-27 20:32","pubTimestamp":1779885120,"startTime":"0","endTime":"0","summary":"证券日报网5月27日讯，上海医药在接受调研者提问时表示，公司始终致力于优化业务结构，提升盈利水平，确保高质量发展。一方面对于存量业务，通过进一步提质增效，优化成本结构，保持毛利水平。另一方面，通过巩固创新业务优势和开拓第二增长曲线，打造新的增长引擎。在现金流管理方面，公司始终高度重视现金流安全，坚持审慎稳健的财务管控原则，通过应收账款管理、严控资本开支、优化营运资本周转等方式筑牢资金安全底线，保障公司持续健康运营。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-05-27/doc-inhzizpk9145408.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-05-27/doc-inhzizpk9145408.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0175","BK0012","BK0099","BK0028","BK0020","BK0196","BK0187","BK0188","BK1197","02607","BK0184","601607","BK0097","BK0209","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638503976","title":"上海医药(02607)：杨秋华、沈波、李永忠及董明获提名为执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2638503976","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638503976?lang=zh_cn&edition=full","pubTime":"2026-05-27 17:06","pubTimestamp":1779872765,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药(02607)发布公告，于2026年5月27日召开的董事会会议上，提名第九届董事会董事候选人名单如下：(i)杨秋华先生、沈波先生、李永忠先生及董明先生为第九届董事会的执行董事;(ii)张文学先生为第九届董事会的非执行董事;(iii)王忠先生、万钧女士、薛云奎先生及王迁先生为第九届董事会的独立非执行董事。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446611.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0099","BK0012","BK0209","601607","BK0028","BK0184","BK1197","BK0097","BK0187","BK0020","BK0188","02607","BK0196","BK0175","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634041495","title":"每周股票复盘：上海医药（601607）利伐沙班片获泰国注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2634041495","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634041495?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:29","pubTimestamp":1778351351,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，上海医药报收于17.07元，较上周的17.09元下跌0.12%。本周，上海医药5月7日盘中最高价报17.2元。本周关注点公司公告汇总：利伐沙班片获泰国药品注册证书，具备上市销售资格。2025年5月该药品已获美国FDA批准，2025年10月获马来西亚注册证书，2026年2月获新加坡注册证书。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000000889.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","BK0012","BK0020","601607","BK0188","02607","BK0099","BK0196","BK0028","BK0175","BK0187","BK0183","BK0097","BK0184","BK1197"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633431583","title":"上海医药（601607）披露持股5%以上股东权益变动触及1%刻度的提示性公告，5月8日股价下跌0.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633431583","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633431583?lang=zh_cn&edition=full","pubTime":"2026-05-08 17:35","pubTimestamp":1778232954,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，上海医药报收于17.07元，较前一交易日下跌0.35%，最新总市值为633.02亿元。本次权益变动后，控股股东及其一致行动人合计持股比例由38.03%上升至39.00%，增持行为符合相关法律法规，未触发强制要约收购义务，不导致公司控制权变更。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800031515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0012","02607","BK0196","BK0099","BK0209","BK1197","601607","BK0184","BK0188","BK0097","BK0183","BK0175","BK0020","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633116429","title":"东南亚市场再下一城：上海医药附属公司利伐沙班片在泰国获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2633116429","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633116429?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:36","pubTimestamp":1778142960,"startTime":"0","endTime":"0","summary":"5月7日，上海医药（601607/02607）发布公告，公司下属常州制药厂有限公司生产的利伐沙班片收到泰国食品药品监督管理局颁发的药品注册证书，该药品获得批准上市。利伐沙班片主要用于降低非瓣膜性房颤患者卒中和全身性栓塞的风险、治疗和预防深静脉血栓形成、用于治疗肺栓塞及预防急性病患者静脉血栓栓塞等。截至本公告日，公司针对该药品在东南亚市场上市另投入的研发费用约324.82万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605073730110589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0175","BK0097","BK0099","BK0183","BK0188","601607","BK0187","BK1197","IPOS","BK0209","02607","BK0020","BK0196","BK0028","BK0184","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633974268","title":"大摩：上海医药(02607)首季业绩符预期 予上海医药(601607.SH)A股“与大市同步”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2633974268","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633974268?lang=zh_cn&edition=full","pubTime":"2026-05-06 10:14","pubTimestamp":1778033691,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根士丹利发布研报称，上海医药(02607)首季收入为753亿元人民币，同比增长6.4%，纯利为14.18亿元人民币，同比增长6.4%，两者均符合该行预期。大摩提到，上海医药目前正与美国及欧盟跨国的企业，就其研发管线的潜在业务发展机会进行磋商。该行予上海医药(601607.SH)A股“与大市同步”评级，目标价18.8元人民币。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438343.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601607","02607","399300","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633925374","title":"格隆汇沽空预警榜 | 5月4日","url":"https://stock-news.laohu8.com/highlight/detail?id=2633925374","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633925374?lang=zh_cn&edition=full","pubTime":"2026-05-06 02:15","pubTimestamp":1778004900,"startTime":"0","endTime":"0","summary":"格隆汇勾股大数据显示，上一交易日大市沽空比例为21.54%，过去两个月大市日均沽空比例为20.42%。其中，PP中新经济-U、X南方中五百、吉利汽车-R沽空比率排名前三位，分别为100.00%、100.00%、100.00%。小米集团-W、盈富基金、阿里巴巴-W的沽空金额排名前三位，分别为30.98亿、28.52亿、15.97亿。IFBH、中国中免、上海医药的偏离值排名前三位，分别为9.28、9.09、6.18。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2026/05/06021557004862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU2257852520.SGD","XIACY","LU2249611893.SGD","LU0197773160.USD","LU2476274720.SGD","01858","LU0130103400.USD","HK0000320264.USD","LU1956131251.USD","LU2242644610.SGD","LU0516423174.USD","LU1244550221.USD","LU1917777945.USD","SG9999004220.SGD","PMRTY","LU0831093199.SGD","BK1161","LU0640798160.USD","LU2097828805.USD","LU1831875114.USD","HK0000165453.HKD","IE0008368742.USD","LU0072462343.USD","LU2153592121.USD","LU0588546209.SGD","HK0000352382.USD","SG9999006597.SGD","IE0003895053.USD","LU1804176565.USD","LU0359201612.USD","SG9999001051.SGD","LU0823397285.USD","300759","SG9999015945.SGD","LU0516422366.SGD","BK1249","LU0831103253.SGD","LU1064130708.USD","LU0456827905.SGD","LU1868838027.USD","LU2087589342.USD","BK1523","LU2357125470.USD","BK1516","LU0862451753.SGD","LU0918141887.USD","LU0345776255.USD","HK0000914660.USD","LU1226287529.USD","LU1303224171.USD","TCHmain","LU0173614495.USD","LU0823039010.USD","BK1575","LU0431992006.USD","LU0823041008.USD","LU1691799644.USD","LU0543330566.HKD","BK1517","LU2317271919.USD","LU0918141705.HKD","SHPMY","LU0210533765.USD","LU0049853897.USD","LU0543330483.HKD","LU1282648689.USD","BK1197","LU2023250504.SGD","LU0762540952.USD","LU1733274473.HKD","LU2449936058.SGD","09992","LU0329678170.USD","LU0499858438.USD","BK1095","BK1521","LU0611395673.USD","HK0000107257.USD","LU0572940350.SGD","LU1105468828.SGD","IE0009570106.USD","03137","SG9999000418.SGD","LU0106252389.USD","BK1144","LU0396098781.USD","LU0320764755.SGD","IE00B8L5B284.USD","LU0132412106.USD","LU1993786604.SGD","IE0031814852.USD","LU0898667661.SGD","SG9999001903.USD","LU0181495838.USD","LU0502904849.HKD","LU0488056044.USD","LU0348723411.USD","LU0414403682.SGD","89988","LU0261950983.USD","LU1282649810.SGD","BK1597","LU0326948709.USD","LU0828237940.HKD","09988","IE0032431581.USD","IE00B067MR52.USD","HK0001040168.HKD","IE00BZ08YS42.EUR","LU0634319403.HKD","LU0449515922.USD","LU1439102457.SGD","LU0293314216.USD","LU0878004406.USD","LU0823038988.USD","LU0370786039.SGD","LU1242518931.SGD","LU0107464264.USD","82333","SG9999002950.SGD","LU1226287792.SGD","LU1282649067.USD","LU0607220059.USD","IE0008368304.USD","02800","IE00BQXX3C00.GBP","LU0737861772.HKD","LU1064131003.USD","LU0130518102.USD","LU0588545490.SGD","LU3063872942.SGD","LU1734074674.USD","LU0315178854.USD","LU0455707207.USD","LU1188198961.HKD","LU1152091754.HKD","LU0588545730.USD","LU1226288097.SGD","BK1539","SG9999002828.SGD","LU0348816934.USD","HK0000914686.HKD","83189","LU1861214812.USD","SG9999015978.USD","LU0477156797.USD","LU0791590937.USD","LU1720051017.SGD","LU1211504680.USD","BK1224","81211","LU2133065610.SGD","LU0211977185.USD","LU0052750758.USD","SG9999001226.SGD","LU1226288253.USD","SGXZ99366536.SGD","LU0251144936.SGD","LU0140636845.USD","LU0348825331.USD","02431","LU2362540622.SGD","LU0823397103.USD","LU1720050803.USD","IE00BZ08YT58.USD","LU0192582467.USD","LU0417516902.SGD","LU1201861165.SGD","LU0320764243.SGD","LU2357305700.SGD","LU0762541174.USD","LU2488822045.USD","LU1861219969.SGD","IE00BQXX3F31.USD","SG9999011746.SGD","09173","IE00B031HY20.USD","BK1171","LU0359202008.SGD","002594","LU0326950275.SGD","LU1244550577.SGD","LU0327786744.USD","LU0823413587.USD","LU2226246903.HKD","GB00BDT5M118.USD","LU1046422090.SGD","LU0821914370.USD","LU0289960550.SGD","LU0791591158.USD","LU0572939691.SGD","LU0348788117.USD","IE00BPRC5H50.USD","LU1048588211.SGD","LU0572944931.SGD","LU0672654166.SGD","LU0985320562.USD","LU0169518387.USD","LU0229945570.USD","IE00BQXX3D17.EUR","LU0049112450.USD","LU0441854154.USD","IE0008368411.USD","03005","LU1808992512.USD","LU0143863784.USD","LU2360107325.USD","LU0823426308.USD","BK1237","LU0106959298.USD","LU0231483743.USD","LU0314109678.HKD","LU0762542818.HKD","SG9999002463.SGD","LU0608807946.USD","LU0577902611.USD","81810","LU1974910355.USD","IE00BGV7N243.SGD","LU0593848301.USD","SG9999014914.USD","BK1583","LU1224444064.USD","LU1785774172.SGD","601633","LU0873338254.USD","LU1282649141.HKD","LU0329678337.USD","LU1282651048.USD","LU2399975544.HKD","LU0149534421.HKD","LU0650527681.SGD","LU1642822792.SGD","LU1883866441.USD","02410","SGXZ51526630.SGD","LU2152927971.USD","601607","BK1607","03958","BK1588","LU0577902454.USD","LU1251922891.USD","LU1770036033.HKD","IE0008369823.USD","LU0128522744.USD","LU2348774022.SGD","LU0417516571.SGD","LU0648948544.HKD","BK1564","LU2251237488.HKD","601888","BYDDY","LU0228659784.USD","LU0117844026.USD","LU0164865239.USD","LU1008478684.HKD","LU0516422952.EUR","LU2008162690.USD","IE00BF5LJ272.USD","LU0541501648.USD","BK1610","LU1769817096.USD","LU1733274390.USD","HK0000320223.HKD","LU1868837565.USD","LU2294711713.HKD","LU0048388663.USD","LU0061477393.USD","LU0516423091.SGD","LU0856984785.SGD","BK1586","LU1814569148.SGD","LU0348767384.USD","LU1504937902.USD","BK1584","LU1629966141.USD","00700","LU1807302812.USD","ALBmain","LU1880383440.USD","LU0188438112.USD","LU0463099449.HKD","IE00BD6J9T35.USD","LU0633140560.USD","IE00B0169L03.USD","SG9999017495.SGD","BK1506","LU0594300419.USD","LU0505663152.USD","HSI","BK1119","LU0871576103.HKD","BK1531","LU0630378429.USD","LU2251237306.USD","LU0348814723.USD","LU0196878994.USD","SG9999002562.SGD","IE00BMPRXN33.USD","LU1718418525.SGD","LU0516422440.USD","LU0384037296.USD","LU1048596156.SGD","SGXZ81514606.USD","LU0269904917.USD","LU2039709279.SGD","BK1147","LU0070217475.USD","IE0003851619.USD","LU0106259558.USD","LU1725190679.HKD","IE00B031HW06.USD","LU1051769294.HKD","LU0577902538.SGD","IE00B97KM107.HKD","LU1044874839.SGD","LU0289739343.SGD","LU1102505762.USD","LU0348783662.USD","LU0880133367.SGD","LU0828237510.HKD","02338","LU2279701549.SGD","09803","BK1509","HYDD.SI","SG9999014674.SGD","LU1242518857.USD","LU0348827113.USD","LU0235996351.USD","LU1880398554.USD","LU2265009873.SGD","LU0348783233.USD","LU1226287875.USD","BK1608","01211","LU0264606111.USD","LU1960683339.HKD","LU0211331839.USD","LU2362541273.HKD","LU2778985437.USD","BK1141","BK1582","LU1568876335.HKD","LU2237443978.SGD","IE00B5MMRT66.SGD","LU0348766576.USD","MIUmain","LU0594300179.USD","LU0469268626.HKD","LU0328353924.USD","LU1328277881.USD","LU0878005551.USD","BK1540","HXXD.SI","HK0001040143.USD","06603","BK1589","LU0605514214.HKD","LU2237443382.USD","LU0456842615.SGD","LU0048580855.USD","LU0630378692.HKD","LU0228367735.SGD","LU2097828474.EUR","LU0823414551.USD","LU0348735423.USD","LU0823426480.USD","LU1810669033.SGD","LU1868837722.USD","83111","LU0210527791.USD","LU0348805143.USD","LU0865486749.SGD","LU2097828557.USD","LU0244354667.USD","LU0797268264.HKD","LU1196710195.USD","BK1142","01951","SG9999001069.SGD","IE00BMPRXR70.SGD","LU0589944569.HKD","03759","LU0588545904.SGD","HTCD.SI","LU0051755006.USD","LU0315179316.USD","LU2097828714.EUR","LU0499858602.USD","LU0540923850.HKD","LU0039217434.USD","LU0054237671.USD","SG9999015952.SGD","IE00B3M56506.USD","LU1675838814.USD","IE00B29SXG58.USD","LU2125910500.SGD","LU0029875118.USD","LU1224709979.USD","LU0608807433.USD","LU1951186391.HKD","LU2237443465.HKD","LU0259732245.USD","BABA","SGXZ90724238.SGD","LU1688375341.USD","IE0003795394.USD","LU0577902298.EUR","LU0509642566.USD","BK1526","SGXZ62798434.SGD","IE00B543WZ88.USD","BK1502","SG9999000327.SGD","LU0289961442.SGD","LU2177674079.SGD","LU0287142896.SGD","LU0011963245.USD","LU1366334651.USD","HK0000306701.USD","LU0197773673.USD","LU0307460666.USD","LU0700851271.USD","LU1044876610.USD","LU1044875133.USD","LU1316542783.SGD","GWLLY","LU0819121731.USD","LU2476274308.USD","BK1594","IE0034224299.USD","LU1439103000.SGD","BK1615","LU2045819591.USD","LU1051768304.USD","LU2097829019.USD","LU0456846285.SGD","LU0165289439.USD","LU1981816686.USD","SG9999001093.SGD","LU1961090484.USD","LU0214875030.USD","SG9999003461.SGD","IE0032834883.USD","SG9999001846.SGD","LU0345769631.USD","LU1794554557.SGD","BK1501","LU2237443895.HKD","LU2506951792.HKD","LU0651946864.USD","IE00B0JY6N72.USD","BK1609","LU0501845795.SGD","LU1196710351.USD","LU2148510915.USD","80175","LU1226288170.HKD","LU0345769128.USD","LU0261947096.USD","SGXZ86797644.SGD","02587","LU0047713382.USD","LU0096374516.USD","LU0651947912.USD","LU1568876251.USD","LU0633140727.USD","LU2362541513.USD","IE00B031J352.USD","LU0819123356.HKD","LU1235295612.USD","HK0000352291.HKD","LU2247934214.USD","LU2543165471.USD","01880","BK1585","LU2294711473.HKD","LU0320764599.SGD","LU0890818403.SGD","LU1366334578.USD","SG9999000459.SGD","LU0127658192.USD","LU1048484197.HKD","LU0784639295.USD","LU0823040885.USD","SG9999006514.SGD","LU2106854487.HKD","LU1515016050.SGD","LU1880383366.USD","LU0541502299.USD","LU0531970944.HKD","LU0080751232.USD","BK1522","HSTECH","LU0648000940.SGD","LU0823414478.USD","LU0972618739.USD","LU1481107354.HKD","SG9999018857.SGD","LU1102505929.USD","LU1720051108.HKD","SG9999007991.SGD","02607","LU0072913022.USD","SG9999014880.SGD","LU1655091459.SGD","LU0531971595.HKD","IE00BZ08YR35.GBP","LU2125910849.SGD","BK1193","LU0823413660.USD","SG9999018865.SGD","LU0828238088.HKD","LU0577902371.SGD","LU1244550494.USD","LU0210526637.USD","09159","LU0149721374.USD","BK1618","LU0348784397.USD","LU0708995583.HKD","SG9999013353.USD","LU2462611646.USD","HK0000306685.HKD","LU0561508036.HKD","SG9999001689.USD","LU1548497426.USD","LU0642271901.SGD","LU0886674414.USD","LU1770034418.SGD","LU1023057109.AUD","LU0737861699.HKD","LU0164872284.USD","LU0084288322.USD","BK1591","LU0203347892.USD","HBBD.SI","LU1282651121.HKD","HK0000286598.CNH","HK0000151867.HKD","LU0163747925.USD","LU0979878070.USD","000338","LU1115378108.SGD","LU0511384066.AUD","SG9999014906.USD","LU0164880469.USD","LU2097828631.EUR","LU0708995153.HKD","01810","LU0345775950.USD","LU0128522157.USD","SGXZ31699556.SGD","LU0043850808.USD","TCEHY","LU2498475776.HKD","BK1576","IE00B0169N27.USD","LU0738912210.USD","LU1769817179.HKD","LU0143863198.USD","IE0001KFT4U8.USD","LU0203345920.USD","BK1100","LU0868486357.SGD","SG9999014898.SGD","LU0067412154.USD","SG9999015986.USD","LU0882747503.HKD","LU1196710864.SGD","LU0675040207.SGD","LU0449509016.USD","LU1323998911.USD","BK1219","LU0359201885.HKD","03033","LU1152091168.USD","LU0417516738.SGD","LU2237443549.SGD","LU0254981946.USD","LU0683595622.HKD","LU0117841782.USD","LU0175139822.USD","LU1813983027.USD","LU1719994722.HKD","LU0786609619.USD","LU2237443622.USD","LU2293587155.HKD","688236","LU0862451837.USD","IE00B8HQ1Z84.USD","LU2051468812.USD","LU0054450605.USD","LU1328615791.USD","LU0029874905.USD","LU1880398471.USD","LU0048597586.USD"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2632647733","title":"每周股票复盘：上海医药（601607）一季度营收752.62亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2632647733","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632647733?lang=zh_cn&edition=full","pubTime":"2026-05-02 04:33","pubTimestamp":1777667591,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，上海医药报收于17.09元，较上周的16.88元上涨1.24%。本周，上海医药4月30日盘中最高价报17.12元。本周关注点来自业绩披露要点：上海医药2026年一季报显示，一季度主营收入752.62亿元，同比上升6.36%。上海医药2026年第一季度实现营业收入752.62亿元，同比增长6.36%；归属于上市公司股东的净利润14.18亿元，同比增长6.35%。上海医药集团股份有限公司第八届董事会第三十次会议于2026年4月29日召开，会议应到董事10名，实到10名，符合法定人数要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200002777.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02607","601607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632677836","title":"上海医药（601607）2026年一季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2632677836","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632677836?lang=zh_cn&edition=full","pubTime":"2026-05-01 06:20","pubTimestamp":1777587634,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期上海医药发布2026年一季报。截至本报告期末，公司营业总收入752.62亿元，同比上升6.36%，归母净利润14.18亿元，同比上升6.35%。本报告期上海医药盈利能力上升，毛利率同比增幅4.86%，净利率同比增幅6.05%。本次财报公布的各项数据指标表现尚佳。持有上海医药最多的基金为工银创新动力股票，目前规模为16.74亿元，最新净值1.273，较上一交易日下跌0.62%，近一年上涨16.88%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050100004998.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["02607","601607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111906483","title":"上海医药2026年第一季度营收752.62亿元，经调整净利润12.38亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1111906483","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1111906483?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:11","pubTimestamp":1777453866,"startTime":"0","endTime":"0","summary":"2026年第一季度，上海医药实现营业收入752.62亿元，同比增长6.36%。经调整净利润12.38亿元，同比下降2.02%。同期内，公司经营活动产生的现金流量净额为-10.10亿元，较上年同期的-22.04亿元显著改善，同比增长54.19%。报告期内，公司综合营业成本为728.26亿元，高于上年同期的686.67亿元。销售费用为32.75亿元，管理费用13.16亿元，财务费用3.57亿元。医药工业板块实现销售收入68.06亿元，同比增长15.64%；医药商业板块实现销售收入684.56亿元，同比增长5.52%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"上海医药2026年第一季度营收752.62亿元，经调整净利润12.38亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631598761","title":"上海医药(02607)一季度归母净利润14.18亿元 同比增长6.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2631598761","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631598761?lang=zh_cn&edition=full","pubTime":"2026-04-29 17:04","pubTimestamp":1777453483,"startTime":"0","endTime":"0","summary":"智通财经APP讯，上海医药(02607)发布2026年第一季度报告，营业收入752.62亿元(人民币，下同)，同比增长6.36%。归属于上市公司股东的净利润14.18亿元，同比增长6.35%。基本每股收益0.3823元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436207.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601607","02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631537129","title":"上海医药清仓中美施贵宝 高瓴系公司接盘；百洋医药一季度净利润增加近46% | 医药早参","url":"https://stock-news.laohu8.com/highlight/detail?id=2631537129","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631537129?lang=zh_cn&edition=full","pubTime":"2026-04-29 07:04","pubTimestamp":1777417480,"startTime":"0","endTime":"0","summary":"丨2026年4月29日星期三丨NO.1泰格医药一季度净利润同比减少70.36%4月28日，泰格医药发布2026年一季报，公司实现营业收入18.01亿元，同比增加15.17%；实现归属于上市公司股东的净利润4904.31万元，同比减少70.36%；实现归属于上市公司股东的扣除非经常性损益的净利润1.20亿元，同比增加17.65%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604293723254882.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604293723254882.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02607","BMY","159938","09939","601607","301015"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167025210","title":"上海医药(02607)2025年度营收达2835.80亿元 研发投入稳步提升 利润与现金流同步改善","url":"https://stock-news.laohu8.com/highlight/detail?id=1167025210","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167025210?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:46","pubTimestamp":1777365987,"startTime":"0","endTime":"0","summary":"上海医药披露2025年年度报告，显示公司整体收入稳步增长，核心业务持续扩张，盈利能力与现金流同步改善。2025年公司实现营业收入人民币2,835.80亿元，较2024年的2,752.51亿元增长2.97%。营业成本为人民币2,531.63亿元，增幅3.69%，与收入增长基本保持一致。截至2025年12月31日，集团总资产为人民币2,331.49亿元，较上年增长5.40%；流动资产合计为人民币1,804.64亿元。整体来看，上海医药在2025年继续维持业绩增势，营业收入与净利润均实现稳中有升，经营活动现金流也进一步增强。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"上海医药(02607)2025年度营收达2835.80亿元 研发投入稳步提升 利润与现金流同步改善","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630047801","title":"每周股票复盘：上海医药（601607）泼尼松龙片通过一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2630047801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630047801?lang=zh_cn&edition=full","pubTime":"2026-04-26 03:13","pubTimestamp":1777144390,"startTime":"0","endTime":"0","summary":"截至2026年4月24日收盘，上海医药报收于16.88元，较上周的16.99元下跌0.65%。本周关注点公司公告汇总：泼尼松龙片通过仿制药一致性评价，有利于提升市场竞争力公司公告汇总：泼尼松龙片一致性评价研发投入约800万元公司公告汇总：2025年大陆医院采购金额为224.7万元公司公告汇总上海医药集团股份有限公司下属天津信谊津津药业有限公司收到国家药监局颁发的泼尼松龙片《药品补充申请批准通知书》，该药品通过仿制药质量和疗效一致性评价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042600001259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0097","BK0012","02607","BK0099","BK0184","BK1197","BK0209","BK0188","BK0020","BK0196","BK0175","BK0183","BK0187","601607","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629176718","title":"上海医药：附属公司泼尼松龙片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2629176718","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629176718?lang=zh_cn&edition=full","pubTime":"2026-04-24 18:02","pubTimestamp":1777024920,"startTime":"0","endTime":"0","summary":"4月24日，上海医药（601607/02607）发布公告，公司下属天津信谊津津药业有限公司的泼尼松龙片通过仿制药一致性评价。泼尼松龙片主要用于过敏性与自身免疫性炎症性疾病，胶原性疾病。截至本公告日，公司针对该药品的一致性评价已投入研发费用约800万元。2025年，上海医药实现收入2835.80亿元，归母净利润57.25亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604243718154291.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0012","BK0097","02607","BK0184","BK1197","601607","BK0196","BK0209","BK0188","BK0028","BK0099","BK0183","BK0175","BK0187","BK0020"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.shaphar.com.cn","stockEarnings":[{"period":"1week","weight":0.0113},{"period":"1month","weight":-0.0068},{"period":"3month","weight":0.0336},{"period":"6month","weight":-0.0097},{"period":"1year","weight":0.0669},{"period":"ytd","weight":0.0264}],"compareEarnings":[{"period":"1week","weight":0.0171},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0312},{"period":"6month","weight":0.0039},{"period":"1year","weight":0.1244},{"period":"ytd","weight":0.0159}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海医药集团股份有限公司是一家主要从事医药分销业务的中国公司。该公司主要经营四个业务分部。工业分部主要从事药品及保健品的研发、生产和销售。分销分部主要从事向医药制造商及配药商提供分销、仓储和其他增值医药供应链解决方案及相关服务。零售分部主要从事经营及加盟零售药店网络。其他分部主要从事其他业务。该公司主要在国内市场经营其业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.005835},{"month":2,"riseRate":0.533333,"avgChangeRate":0.014987},{"month":3,"riseRate":0.533333,"avgChangeRate":0.009535},{"month":4,"riseRate":0.533333,"avgChangeRate":0.000642},{"month":5,"riseRate":0.466667,"avgChangeRate":-0.003715},{"month":6,"riseRate":0.5,"avgChangeRate":-0.008724},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.017077},{"month":8,"riseRate":0.4,"avgChangeRate":0.011563},{"month":9,"riseRate":0.333333,"avgChangeRate":0.013086},{"month":10,"riseRate":0.266667,"avgChangeRate":-0.021401},{"month":11,"riseRate":0.466667,"avgChangeRate":0.029705},{"month":12,"riseRate":0.533333,"avgChangeRate":-0.012575}],"exchange":"SEHK","name":"上海医药","nameEN":"SH PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供上海医药(02607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"上海医药,02607,上海医药股票,上海医药股票老虎,上海医药股票老虎国际,上海医药行情,上海医药股票行情,上海医药股价,上海医药股市,上海医药股票价格,上海医药股票交易,上海医药股票购买,上海医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"上海医药(02607)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供上海医药(02607)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}